Detalhe da pesquisa
1.
Benralizumab in severe eosinophilic asthma by previous biologic use and key clinical subgroups: real-world XALOC-1 programme.
Eur Respir J
; 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38575162
2.
Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients: An APEX Trial Substudy (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban).
Circulation
; 135(7): 648-655, 2017 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-27881569
3.
Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy.
Circulation
; 135(4): 323-333, 2017 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-27881555
4.
The safety and efficacy of full- versus reduced-dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended-Duration Betrixaban (APEX) trial.
Am Heart J
; 185: 93-100, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28267480
5.
Competing risk analysis in a large cardiovascular clinical trial: An APEX substudy.
Pharm Stat
; 16(6): 445-450, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28840662
6.
Safety, Efficacy and Pharmacokinetics of AZD7442 (Tixagevimab/Cilgavimab) for Treatment of Mild-to-Moderate COVID-19: 15-Month Final Analysis of the TACKLE Trial.
Infect Dis Ther
; 13(3): 521-533, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38403865
7.
Analysis of SARS-CoV-2 Emergent Variants Following AZD7442 (Tixagevimab/Cilgavimab) for Early Outpatient Treatment of COVID-19 (TACKLE Trial).
Infect Dis Ther
; 12(12): 2691-2707, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37914983
8.
Outpatient Treatment with AZD7442 (Tixagevimab/Cilgavimab) Prevented COVID-19 Hospitalizations over 6 Months and Reduced Symptom Progression in the TACKLE Randomized Trial.
Infect Dis Ther
; 12(9): 2269-2287, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37751015
9.
Efficacy and safety of intramuscular administration of tixagevimab-cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial.
Lancet Respir Med
; 10(10): 985-996, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35688164
10.
Comparison of Fatal or Irreversible Events With Extended-Duration Betrixaban Versus Standard Dose Enoxaparin in Acutely Ill Medical Patients: An APEX Trial Substudy.
J Am Heart Assoc
; 6(7)2017 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28698258